Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 3 drugs
Casirivimab is a monoclonal antibody combined with Imdevimab in Regeneron's antibody cocktail known as REGN-COV2 for the treatment of COVID-19. This drug is a combination of antibodies derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19. These antibodies have been formulated to...
Approved
Experimental
Matched Synonyms: … Casirivimab
Matched Name: … Casirivimab
Matched Description: … Casirivimab and imdevimab are investigational recombinant human IgG1 monoclonal antibodies that, at this ... Casirivimab is a monoclonal antibody combined with [Imdevimab] in Regeneron's antibody cocktail known ... [L39130,L39135] Full safety and efficacy data are not yet available, and further evaluation of this …
Matched Mixtures name: … Casirivimab and Imdevimab ... Casirivimab and Imdevimab ... Casirivimab With Imdevimab
Matched Categories: … casirivimab and imdevimab ... Amino Acids, Peptides, and Proteins ... Immune Sera and Immunoglobulins …
Matched Products: … Casirivimab
Imdevimab is a monoclonal antibody combined with casirivimab in Regeneron's antibody cocktail known as REGEN-COV2 for the treatment of COVID-19. This drug is a combination of antibodies derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19. These antibodies have been formulated to...
Approved
Experimental
Matched Synonyms: … Imdevimab
Matched Name: … Imdevimab
Matched Description: … Casirivimab and imdevimab are investigational recombinant human IgG1 monoclonal antibodies that, at this ... Imdevimab is a monoclonal antibody combined with [casirivimab] in Regeneron's antibody cocktail known ... [L39130,L39135] Full safety and efficacy data on imdevimab are not yet available, and further evaluation …
Matched Mixtures name: … Casirivimab and Imdevimab ... Casirivimab and Imdevimab ... Casirivimab With Imdevimab
Matched Categories: … casirivimab and imdevimab ... Amino Acids, Peptides, and Proteins ... Immune Sera and Immunoglobulins …
Matched Products: … Imdevimab
Bebtelovimab (LY-COV1404, LY-3853113) is a human monoclonal antibody approved for emergency use in the treatment of COVID-19. It binds to a portion of the SARS-CoV-2 spike (S) protein's receptor-binding domain, thereby preventing spike protein interaction with ACE2 and subsequent viral entry into host cells. Bebtelovimab is notable in that the...
Investigational
Withdrawn
Matched Description: … ], and [imdevimab] - which have been found ineffective in the treatment of COVID-19 caused by the Omicron ... previously developed COVID-19 monoclonal antibody treatments - including [bamlanivimab], [etesevimab], [casirivimab ... spike (S) protein's receptor-binding domain, thereby preventing spike protein interaction with ACE2 and
Matched Categories: … Amino Acids, Peptides, and Proteins …
Displaying all 3 drugs